PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
15-Apr-2024 Germfree and Orgenesis announce asset purchase and strategic partnership intended to revolutionize cell and gene therapy through decentralized production and global accessibility Germfree and Orgenesis
15-Apr-2024 Dot Compliance Raises a $17.5 Million Up-Round in Series B Extension Funding to Advance New Category of AI-driven Compliance Dot Compliance
15-Apr-2024 FASENRA approved for treatment of children aged 6 to 11 with severe asthma - Additional indication for pediatric patients with severe eosinophilic asthma Astrazeneca
15-Apr-2024 PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers PureTech Health plc
15-Apr-2024 PHARMACISTS SAY REGULATED APPROACH TO E-LABELLING IS KEY TO SUCCESSFUL TRANSITION Weber Shandwick
15-Apr-2024 Century Therapeutics to acquire Clade Therapeutics Syncona Limited
11-Apr-2024 AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock AdrenoMed AG
11-Apr-2024 New insight into combatting drug-resistant prostate cancer University of Eastern Finland
11-Apr-2024 EFA Technologies, pioneer in portable blood labs, enters Brazilian market after Anvisa approval of its portable RevDx device EFA Technologies
11-Apr-2024 Qinecsa Host Industry Discussion on Mastering Medical Device Regulations to Integrate Devices into Pharma Portfolios Qinecsa
11-Apr-2024 Qinecsa Solutions announces acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions Qinecsa
11-Apr-2024 AbbVie’s AQUIPTA® (atogepant) Is Recommended By NICE For The Prevention Of Migraine In Adults AbbVie
09-Apr-2024 Gilead extends partnership with NHS England to eliminate hepatitis C by 2025 Gilead Sciences, Inc
09-Apr-2024 PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions PureTech Health plc
09-Apr-2024 Lundbeck and Otsuka submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD Lundbeck
09-Apr-2024 Bios Health Group Unveils Bios Innovation Circle™ Bios Health Group
09-Apr-2024 KITE TO PRESENT COMPARISON OF OUTCOMES OF TECARTUS® (BREXUCABTAGENE AUTOLEUCEL) FROM THE PIVOTAL ZUMA-2 TRIAL VERSUS THE EBMT REGISTRY OF ALLOSCT PATIENTS IN MANTLE CELL LYMPHOMA (MCL) AT 50TH EBMT 2024 KITE
09-Apr-2024 OncoZenge Appoints Åsa Nilsson as Clinical Research Manager OncoZenge
09-Apr-2024 iiCON launches new platform with the Centre of Excellence for Long-Acting Therapeutics iiCON
09-Apr-2024 Andaman7 Launches AI Supercharged Personal Health Record v5 Andaman7